ECZEMA
CLINCAL STUDY

NOW UNDERWAY IN PLAINFIELD

About Eczema

Eczema, also known as atopic dermatitis (AD), is an incurable, chronic condition that results in itchy, red, swollen, and cracked skin. Although eczema is not contagious, it is a long-lasting and itchy inflammatory skin disease that impacts both the physical and psychological quality of life for the people who suffer from it.

About the ADORING Study

ADORING is a phase 3 clinical study evaluating the safety and efficacy of tapinarof cream, 1% for the topical treatment of moderate to severe eczema in children aged 2-17.

Although several treatment options are available to treat eczema, we are evaluating tapinarof for application to large areas of the body for long periods of time. Tapinarof is an investigational non-steroidal product that is being evaluated to determine if it may help control eczema signs and symptoms.

Children 2-17 may be eligible to participate in this study.

Participants May Receive:

Study-related care from a qualified medical provider at no cost
Investigational topical medication at no cost
Compensation for time

To connect with the research study coordinator, please enter the following information of the parent or guardian of child:

Please enter first name.

Please enter last name.

Please enter valid email.

Please enter valid mobile number.

Please enter valid zip code.

Your privacy is important to us. By clicking "Submit" you agree to our Privacy Policy and Terms of Use, and agree that we may retain the personal information you provide and share it with personnel involved in the study, or otherwise as described in the Privacy Policy, and we or our affiliates may contact you by phone using automated technology or pre-recorded voicemail or other means including but not limited to text messages (standard messaging rates may apply) regarding research studies.

ECZEMA CLINCAL STUDY